Synthesis of (Z)-3-((5-(benzylthio)-4H-1,2,4-triazol-3-yl)imino)-5-haloindolin-2-one derivatives: combined spectroscopic and computational investigations on the level and activity of matrix metalloproteinases 2 and 9 in cancer cell lines

Abstract

Angiogenesis is an essential factor for cancer progression. Although more attention is paid in angiogenesis on its role in cancer biology, many other non-neoplastic diseases are also angiogenic-dependent. Recently, there is motivation to control cancer via inhibition of angiogenesis. Isatin-based scaffolds have been extensively used as anticancer agents in the recent years. Although some biological properties of isatin-based scaffolds are determined, their effects on angiogenesis are rare. So, we investigated the antiangiogenic effects of isatin-1,2,4-triazole conjugates. (Z)-3-((5-(benzylthio)-4H-1,2,4-triazol-3-yl)imino)-5-haloindolin-2-one macromolecules 1a1l were synthesized and characterized, and the buffered solutions were used for evaluation of their cytotoxicity (cell viability) by MTT assay in vitro against U87MG (human glioblastoma astrocytoma) and A2780 (human ovarian carcinoma) cancer cell lines. Also, the effects of the compounds 1a1l on supernatants activities and levels of matrix metalloproteinases (MMP-2 and MMP-9) were assayed using enzyme-linked immunosorbent assay (ELISA) and gelatin zymography. The compounds 1j1l have the greatest cytotoxicity against studied cell lines. Moreover, our observations indicated that 1j1l decreased the supernatants activity of MMP-2 and MMP-9 more than the others and all of the tested compounds considerably decreased the supernatant levels of MMP-9. The molecular mechanism of 1j binding to MMP-2 and MMP-9 was investigated by fluorescence quenching, absorption spectroscopy, FT-IR, molecular docking and molecular dynamics (MD) simulation procedures.

This is a preview of subscription content, access via your institution.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17
Fig. 18
Fig. 19
Fig. 20

References

  1. 1.

    D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100, 57–70 (2000)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    A. Aliabadi, Z. Hasanvand, A. Kiani, S. Mirabdalib, Synthesis and in vitro cytotoxicity assessment of N-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with potential anticancer activity. Iran. J. Pharm. Res. 12, 687–693 (2013)

    CAS  PubMed  PubMed Central  Google Scholar 

  3. 3.

    C. Ruhrberg, Endogenous inhibitors of angiogenesis. J. Cell Sci. 114(18), 3215–3216 (2001)

    CAS  PubMed  PubMed Central  Google Scholar 

  4. 4.

    A. Aliabadi, E. Eghbalian, Kiani A Synthesis and evaluation of the cytotoxicity of a series of 1,3,4-thiadiazole based compounds as anticancer agents. Iran. J. Basic Med. Sci. 16, 1133–1138 (2013)

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    S. Lakhan, M. Avramut, matrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets. Pain Res. Treat. 2012, 10 (2012)

    Google Scholar 

  6. 6.

    A.R. Nelson, B. Fingleton, M.L. Rothenberg, L.M. Matrisian, Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18, 1135–1149 (2000)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    P.F. Mercer, J.K. Shute, A. Bhowmik, G.C. Donaldson, J.A. Wedzicha, J.A. Warner, MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir. Res. 6, 150–159 (2005)

    Article  CAS  Google Scholar 

  8. 8.

    M. Bérubé, A. Deschambeault, M. Boucher, L. Germain, E. Petitclerc, S.L. Guérin, MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Mol. Vis. 11, 1101–1111 (2005)

    PubMed  PubMed Central  Google Scholar 

  9. 9.

    T. Sato, T. Sakai, Y. Noguchi, M. Takta, S. Hirakawa, A. Ito, Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol. Oncol. 92, 47–56 (2004)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    L.A. Di Nezza, A. Misajon, J. Zhang, T. Jobling, M.A. Quinn, A.G. Ostör, G. Nie, A. Lopata, L.A. Salamonsen, Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 2002(94), 1466–1475 (2002)

    Article  CAS  Google Scholar 

  11. 11.

    D.W. Cottam, I.G. Rennie, K. Woods, M.A. Parsons, R.A. Bunning, R.C. Rees, Gelatinolytic metalloproteinase secretion patterns in ocular melanoma. Investig. Ophthalmol. Vis. Sci. 32, 1923–1927 (1992)

    Google Scholar 

  12. 12.

    D.A. Fishman, L. Bafetti, S. Banionis, A.S. Kearns, K. Chilukuri, M.S. Stack, Production of extracellular matrix degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer 80, 1457–1463 (1997)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  13. 13.

    G. Garzetti, A. Ciavattini, G. Lucarini, G. Goteri, M. De Nicolis, S. Garbisa, L. Masiero, C. Romanini, B. Graziella, Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystadenocarcinomas: clinical and prognostic implications. Anticancer Res. 15, 2799–2804 (1995)

    CAS  PubMed  PubMed Central  Google Scholar 

  14. 14.

    K. Gohji, N. Fujomoto, I. Hara, A. Fujii, A. Gotoh, H. Okada, S. Arakawa, S. Kitazawa, H. Miyake, S. Kamidono, M. Nakijima, Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int. J. Cancer 79, 96–101 (1998)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    L. Hou, C. Ju, J. Zhang, J. Song, Y. Ge, W. Yue, Antitumor effects of Isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism. Eur. J. Pharm. 589, 27–31 (2008)

    CAS  Article  Google Scholar 

  16. 16.

    G. Cerchiaro, A.M.C. Ferreira, Oxindoles and copper complexes with oxindole-derivatives as potential pharmacological agents. J. Braz. Chem. Soc. 17, 1473–1485 (2006)

    CAS  Article  Google Scholar 

  17. 17.

    M.C. Rodríguez-Argüelles, R. Cao, A.M. García-Deibe, C. Pelizzi, J. Sanmartín-Matalobos, F. Zani, Antibacterial and antifungal activity of metal(II) complexes of acylhydrazones of 3-isatin and 3-(N-methyl)isatin. Polyhedron 28, 2187–2195 (2009)

    Article  CAS  Google Scholar 

  18. 18.

    A. Patel, S. Bari, G. Talele, J. Patel, M. Sarangapani, Synthesis and antimicrobial activity of some new isatin derivatives. Iran. J. Pharm. Res. 4, 249–254 (2006)

    Google Scholar 

  19. 19.

    P. Pakravan, S. Kashanian, M.M. Khodaei, F.G. Harding, Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity. Pharmacol. Rep. 65, 313–335 (2013)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  20. 20.

    S.N. Pandeya, S. Smitha, M. Jyoti, S.K. Sridhar, Biological activities of isatin and its derivatives. Acta Pharm. 55, 27–46 (2005)

    CAS  PubMed  PubMed Central  Google Scholar 

  21. 21.

    S.N. Pandeya, J.R. Dimmock, Recent evaluations of thiosemicarbazones and semicarbazones and related compounds for antineoplastic and anticonvulsant activities. Pharmazie 48, 659–666 (1993)

    CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    I. Chiyanzu, E. Hansell, J. Gut, P.J. Rosenthal, J.H. McKerrow, K. Chibale, Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg. Med. Chem. Lett. 13, 3527–3530 (2003)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    V.E. Ivanov, N.G. Tikhomirova, A.B. Tomchin, N.V. Razukrantova, Antimicrobial and antibacterial activity of isatin thiosemicarbazones and their complex copper complexes (II) and (I). Pharm. Chem. J. 23, 413–415 (1989)

    Article  Google Scholar 

  24. 24.

    Y. Teitz, D. Ronen, A. Vansover, T. Stematsky, J.L. Riggs, Inhibition of human immunodeficiency virus by N-methylisatin-b-40:40 diethylthiosemicarbazone and N-allyl isatin-b -40:40 diallylthiosemicarbazone. Antiviral Res. 24, 305–314 (1994)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  25. 25.

    H. Adibi, M.M. Khodaei, P. Pakravan, R. Abiri, Synthesis, characterization, and in vitro antimicrobial evaluation of hydrazone and bishydrazone derivatives of isatin. Pharm. Chem. J. 44(4), 219–227 (2010)

    CAS  Article  Google Scholar 

  26. 26.

    S. Kashanian, M.M. Khodaei, P. Pakravan, H. Adibi, Molecular aspects on the interaction of isatin-3-isonicotinylhydrazone to deoxyribonucleic acid: model for intercalative drug-DNA binding. Mol. Biol. Rep. 39(4), 3853–3861 (2012)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    A. Mavrova, D. Wesselinova, Examinations on the cytotoxicity of some 2,5-disubstitute-1,2,4-triazoles and 1,3,4-thiadiazole and their precursors towards guinea hen cells. J. Univ. Chem. Technol. Met. 47, 251–256 (2012)

    CAS  Google Scholar 

  28. 28.

    V. Padmavathi, G.S. Reddy, A. Padmaja, P. Kondaiah, A. Shazia, Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles. Eur. J. Med. Chem. 44, 2106–2112 (2009)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    M.S.R. Murty, K.R. Ram, R.V. Rao, J.S. Yadav, J.V. Rao, R. Pamanji, L.R. Velatooru, Synthesis of new S-alkylated-3-mercapto-1,2,4-triazole derivatives bearing cyclic amine moiety as potent anticancer agents. Lett. Drug Des. Discov. 9, 276–281 (2012)

    CAS  Article  Google Scholar 

  30. 30.

    A. Adibi, N. Zandieh, M. Mansouri, Cytotoxic effects of palladium complexes containing squaric ligands and sulfosuccinic acid on cancer cell lines. J. Kermanshah Univ. Med. Sci. 18(11), 619–630 (2015)

    Google Scholar 

  31. 31.

    H. Adibi, L. Hosseinzadeh, S. Farhadi, F. Ahmadi, Synthesis and cytotoxic evaluation of 6-amino-4-aryl-3-methyl-2, 4-dihydropyrano[2,3-C]pyrazole-carbonitrile derivatives using borax with potential anticancer effects. J. Rep. Pharm. Sci. 2(2), 27–35 (2013)

    Google Scholar 

  32. 32.

    H. Adibi, L. Hosseizadeh, M. Mahdian, A. Foroumadi, M.A. Zolfigol, Synthesis of 7-substituted fluoroquinolone derivatives containing triazolidine dione moiety and in vitro evaluation of their cytotoxic effects. J. Rep. Pharm. Sci. 2(1), 59–66 (2013)

    Google Scholar 

  33. 33.

    H. Adibi, R. Khodarahmi, K. Mansouri, M. Khaleghi, S. Maghsoudi, Synthesis of 4-aryl-4H-chromene derivatives with boric acid: evaluation of their in vitro anti-angiogenesis effects and possible mechanism of action. Pharm. Sci. 19(1), 23–30 (2013)

    Google Scholar 

  34. 34.

    H. Adibi, M.B. Majnooni, A. Mostafaie, K. Mansouri, M. Mohammadi, Synthesis, and In-vitro cytotoxicity studies of a series of triazene derivatives on human cancer cell lines. Iran. J. Pharm. Res. 12(4), 695–703 (2013)

    CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    N. Abdollahpour, A. Asoodeh, M.R. Saberi, J. Chamani, Separate and simultaneous binding effects of aspirin and amlodipine to human serum albumin based on fluorescence spectroscopic and molecular modeling characterizations: a mechanistic insight for determining usage drugs doses. J Lumin. 131(9), 1885–1899 (2011)

    CAS  Article  Google Scholar 

  36. 36.

    S. Ashoka, J. Seetharamappa, P.B. Kandagal, Shaikh SMT Investigation of the interaction between trazodone hydrochloride and bovine serum albumin. J. Lumin. 121(1), 179–186 (2006)

    CAS  Article  Google Scholar 

  37. 37.

    M.R. Ashrafi-Kooshk, N. Moradi, S. Ghobadi, M. Shahlaei, R. Khodarahmi, Spectroscopic study of drug-binding characteristics of unmodified and pNPA-based acetylated human serum albumin: does esterase activity affect microenvironment of drug binding sites on the protein? J. Lumin. 160, 351–361 (2015)

    Article  CAS  Google Scholar 

  38. 38.

    M. Shahlaei, B. Rahimi, M.R. Ashrafi-Kooshk, K. Sadrjavadi, R. Khodarahmi, Probing of possible olanzapine binding site on human serum albumin: combination of spectroscopic methods and molecular dynamics simulation. J. Lumin. 158, 91–98 (2015)

    CAS  Article  Google Scholar 

  39. 39.

    W.K. Surewicz, H.H. Mantsch, D. Chapman, Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment. Biochem 32(2), 389–394 (1993)

    CAS  Article  Google Scholar 

  40. 40.

    A. Naseri, S. Hosseini, F. Rasoulzadeh, M.-R. Rashidi, M. Zakery, Khayamian T (2015) Interaction of norfloxacin with bovine serum albumin studied by different spectrometric methods; displacement studies, molecular modeling and chemometrics approaches. J. Lumin. 157, 104–112 (2015)

    CAS  Article  Google Scholar 

  41. 41.

    D.M. Byler, H. Susi, Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers 25(3), 469–487 (1986)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  42. 42.

    A. Dong, P. Huang, W.S. Caughey, Protein secondary structures in water from second-derivative amide I infrared spectra. Biochem 29(13), 3303–3308 (1990)

    CAS  Article  Google Scholar 

  43. 43.

    H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne, The protein data bank. Nucl. Acids Res. 28(1), 235–242 (2000)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  44. 44.

    G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19(14), 1639–1662 (1998)

    CAS  Article  Google Scholar 

  45. 45.

    H.J. Berendsen, D. van der Spoel, R. van Drunen, GROMACS: a message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 91(1), 43–56 (1995)

    CAS  Article  Google Scholar 

  46. 46.

    B. Hess, C. Kutzner, D. Van Der Spoel, E. Lindahl, GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 4(3), 435–447 (2008)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    S. Melchionna, M. Barteri, G. Ciccotti, Molecular dynamics of microperoxidases in aqueous and nonaqueous solutions. J. Phys. Chem. 100(50), 19241–19250 (1996)

    CAS  Article  Google Scholar 

  48. 48.

    N. Díaz-Vergara, Á. Piñeiro, Molecular dynamics study of triosephosphate isomerase from Trypanosoma cruzi in water/decane mixture. J. Phys. Chem. B 112(11), 3529–3539 (2008)

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  49. 49.

    N. Todorova, F.S. Legge, H. Treutlein, I. Yarovsky, Systematic comparison of empirical forcefields for molecular dynamic simulation of insulin. J. Phys. Chem. B 112(35), 11137–11146 (2008)

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  50. 50.

    D. Van Der Spoel, E. Lindahl, Brute-force molecular dynamics simulations of villin headpiece: comparison with NMR parameters. J. Phys. Chem. B 107(40), 11178–11187 (2003)

    Article  CAS  Google Scholar 

  51. 51.

    A.W. Schüttelkopf, D.M.F. Van Aalten, PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystal Sect. D: Biol. Crystal 60(8), 1355–1363 (2004)

    Article  CAS  Google Scholar 

  52. 52.

    H.J. Berendsen, J.P.M. Postma, W.F. van Gunsteren, A. DiNola, J. Haak, Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81(8), 3684–3690 (1984)

    CAS  Article  Google Scholar 

  53. 53.

    B. Hess, H. Bekker, H.J.C. Berendsen, J.G.E.M. Fraaije, LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18(12), 1463–1472 (1997)

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge Vice Chancellery for Research and Technology, Kermanshah University of Medical Sciences, for financial support (Grant No. 94071). This article resulted from the Pharm. D thesis of Mahdi Rahpeyma, Major of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hadi Adibi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 4979 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kiani, A., Shahlaei, M., Rahpeyma, M. et al. Synthesis of (Z)-3-((5-(benzylthio)-4H-1,2,4-triazol-3-yl)imino)-5-haloindolin-2-one derivatives: combined spectroscopic and computational investigations on the level and activity of matrix metalloproteinases 2 and 9 in cancer cell lines. J IRAN CHEM SOC (2021). https://doi.org/10.1007/s13738-020-02150-3

Download citation

Keywords

  • Isatin
  • 1,2,4-Triazole
  • Matrix metalloproteinases
  • Cytotoxic
  • Computational